Colon Cancer

Showing NaN - NaN of 47

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Genomic Structural Variation in Cancer Susceptibility

Active, not recruiting
  • Breast Cancer
  • +5 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 23, 2022

    NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +3 more
    • Scottsdale, Arizona
    • +84 more
    Oct 10, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

    Recruiting
    • Ovarian Cancer
    • +68 more
    • Phoenix, Arizona
    • +8 more
    Aug 18, 2022

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

    Available
    • Non Small Cell Lung Cancer
    • +6 more
    • Goodyear, Arizona
    • +67 more
    Aug 17, 2022

    Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

    Active, not recruiting
    • Breast Cancer
    • +10 more
    • Los Angeles, California
    • +7 more
    Jun 21, 2022

    Hepatic Metastases, Colon Cancer, Rectal Cancer Trial in United States (Bevacizumab HAI plus systemic chemo, HAI plus systemic

    Active, not recruiting
    • Hepatic Metastases
    • +2 more
    • Bevacizumab HAI plus systemic chemotherapy
    • HAI plus systemic chemotherapy
    • Basking Ridge, New Jersey
    • +4 more
    Apr 26, 2022

    Breast Cancer, Bladder Cancer, Kidney Cancer Trial in New York (PCR/PCR/LDR Strategy)

    Recruiting
    • Breast Cancer
    • +6 more
    • PCR/PCR/LDR Strategy
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Apr 1, 2022

    Biopsy After Radioembolization to Identify Changes in Tumor

    Recruiting
    • Colon Cancer Liver Metastasis
    • +5 more
    • Y90 TARE
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 30, 2022

    Prevention of Colorectal Cancer Through Multiomics Blood Testing

    Recruiting
    • Colon Cancer
    • +10 more
    • Freenome test
    • Anniston, Alabama
    • +173 more
    Mar 9, 2022

    Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

    Terminated
    • Mesothelioma
    • +12 more
    • MGD009
    • Los Angeles, California
    • +19 more
    Feb 4, 2022

    Imaging, Blood, and Tissue Samples to Guide Treatment of Colon

    Recruiting
    • Colon Cancer
    • Liver Tumors
    • blood draws
    • +2 more
    • Basking Ridge, New Jersey
    • +3 more
    Feb 1, 2022

    Ascertainment of Families for Genetic Studies of Familial

    Recruiting
    • Lymphoma
    • +4 more
      • Basking Ridge, New Jersey
      • +5 more
      Oct 7, 2021

      Paper vs. Web vs. Automated Telephone Administration of Patient

      Completed
      • Colon Cancer
      • Rectal Cancer
      • surveys
      • Surveys
      • New York, New York
        Memorial Sloan-Kettering Cancer Center
      Sep 9, 2021

      Colon Cancer, Rectal Cancer Trial in New York (Floxuridine, Oxaliplatin, CPT-11)

      Completed
      • Colon Cancer
      • Rectal Cancer
      • Floxuridine, Oxaliplatin, CPT-11
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jun 29, 2021

      Colon Cancer Trial in New York (Green Tea and Milk Thistle Supplements)

      Unknown status
      • Colon Cancer
      • Green Tea and Milk Thistle Supplements
      • New York, New York
        Mount Sinai St. Luke's Roosevelt Hospital Center
      Feb 22, 2021

      Breast Cancer, Pancreas Cancer, Prostate Cancer Trial in Scottsdale, Duarte, New York (NP-G2-044)

      Completed
      • Breast Cancer
      • +8 more
      • Scottsdale, Arizona
      • +2 more
      Dec 21, 2020

      Medullary Thyroid Cancer, Colon Cancer Trial in New York (Tumor Genomic Analysis)

      Suspended
      • Medullary Thyroid Cancer
      • Colon Cancer
      • Tumor Genomic Analysis
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Oct 14, 2020

      Solid Tumor, Breast Cancer, Colon Cancer Trial in Worldwide (LY3039478, Taladegib, Abemaciclib)

      Completed
      • Solid Tumor
      • +4 more
      • Miami, Florida
      • +10 more
      Aug 13, 2020

      Colon Cancer Trial in New York (THUNDERBEAT, LIGASURE)

      Completed
      • Colon Cancer
      • THUNDERBEAT
      • LIGASURE
      • New York, New York
        Weill Cornell Medical Center- NYPH
      Mar 4, 2020

      Breast Cancer, Cervical Cancer, Prostate Cancer Trial in New York (Color-coded materials, Academic detailing, Standard support)

      Completed
      • Breast Cancer
      • +4 more
      • Color-coded materials
      • +3 more
      • New York, New York
      • +1 more
      Jul 25, 2019

      Colon Cancer, Rectal Cancer, Colorectal Cancer Trial in New York (Genistein)

      Completed
      • Colon Cancer
      • +2 more
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Apr 18, 2019

      Rectal Cancer, Colon Cancer, Crohn's Disease Trial in United States (PINPOINT Endoscopic Fluorescence Imaging System)

      Completed
      • Rectal Cancer
      • +5 more
      • PINPOINT Endoscopic Fluorescence Imaging System
      • Los Angeles, California
      • +10 more
      Nov 19, 2018

      Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer Trial in Worldwide (denosumab)

      Completed
      • Breast Cancer
      • +15 more
      • Encinitas, California
      • +23 more
      Sep 20, 2018

      Depression, Pancreatic Cancer, Lung Cancer Trial in New York (Psychotherapy)

      Terminated
      • Depression
      • +4 more
      • Psychotherapy
      • New York, New York
        New York State Psychiatric Institute
      May 18, 2017